Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy

Dina V. Hingorani, Sandra I. Gonzalez, Jessica F. Li, Mark "Marty" Pagel

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The development and validation of MRI contrast agents consisting of a lanthanide chelate often requires a determination of the concentration of the agent in ex vivo tissue. We have developed a protocol that uses 70% nitric acid to completely digest tissue samples that contain Gd(III), Dy(III), Tm(III), Eu(III), or Yb(III) ions, or the MRI contrast agent gadodiamide. NMR spectroscopy of coaxial tubes containing a digested sample and a separate control solution of nitric acid was used to rapidly and easily measure the bulk magnetic susceptibility (BMS) shift caused by each lanthanide ion and gadodiamide. Each BMS shift was shown to be linearly correlated with the concentration of each lanthanide ion and gadodiamide in the 70% nitric acid solution and in digested rat kidney and liver tissues. These concentration measurements had outstanding precision, and also had good accuracy for concentrations ≥10 mM for Tm(III) Eu(III), and Yb(III), and ≥3 mM for Gd(III), gadodiamide, and Dy(III). Improved sample handling methods are needed to improve measurement accuracy for samples with lower concentrations.

Original languageEnglish (US)
Pages (from-to)13732-13743
Number of pages12
JournalSensors (Switzerland)
Volume13
Issue number10
DOIs
StatePublished - Oct 11 2013

Fingerprint

gadodiamide
Magnetic resonance spectroscopy
Lanthanoid Series Elements
magnetic resonance spectroscopy
Nitric acid
Rare earth elements
Nitric Acid
nitric acid
Magnetic Resonance Spectroscopy
Metals
Tissue
Magnetic susceptibility
Magnetic resonance imaging
Ions
metals
Contrast Media
magnetic permeability
Liver
ions
Nuclear magnetic resonance spectroscopy

Keywords

  • Bulk magnetic susceptibility
  • Concentration measurements
  • Lanthanide metals
  • Magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Electrical and Electronic Engineering
  • Atomic and Molecular Physics, and Optics
  • Analytical Chemistry
  • Biochemistry

Cite this

Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy. / Hingorani, Dina V.; Gonzalez, Sandra I.; Li, Jessica F.; Pagel, Mark "Marty".

In: Sensors (Switzerland), Vol. 13, No. 10, 11.10.2013, p. 13732-13743.

Research output: Contribution to journalArticle

Hingorani, Dina V. ; Gonzalez, Sandra I. ; Li, Jessica F. ; Pagel, Mark "Marty". / Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy. In: Sensors (Switzerland). 2013 ; Vol. 13, No. 10. pp. 13732-13743.
@article{5fc9ed5b1b0b49bb9195ea02b9974c69,
title = "Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy",
abstract = "The development and validation of MRI contrast agents consisting of a lanthanide chelate often requires a determination of the concentration of the agent in ex vivo tissue. We have developed a protocol that uses 70{\%} nitric acid to completely digest tissue samples that contain Gd(III), Dy(III), Tm(III), Eu(III), or Yb(III) ions, or the MRI contrast agent gadodiamide. NMR spectroscopy of coaxial tubes containing a digested sample and a separate control solution of nitric acid was used to rapidly and easily measure the bulk magnetic susceptibility (BMS) shift caused by each lanthanide ion and gadodiamide. Each BMS shift was shown to be linearly correlated with the concentration of each lanthanide ion and gadodiamide in the 70{\%} nitric acid solution and in digested rat kidney and liver tissues. These concentration measurements had outstanding precision, and also had good accuracy for concentrations ≥10 mM for Tm(III) Eu(III), and Yb(III), and ≥3 mM for Gd(III), gadodiamide, and Dy(III). Improved sample handling methods are needed to improve measurement accuracy for samples with lower concentrations.",
keywords = "Bulk magnetic susceptibility, Concentration measurements, Lanthanide metals, Magnetic resonance spectroscopy",
author = "Hingorani, {Dina V.} and Gonzalez, {Sandra I.} and Li, {Jessica F.} and Pagel, {Mark {"}Marty{"}}",
year = "2013",
month = "10",
day = "11",
doi = "10.3390/s131013732",
language = "English (US)",
volume = "13",
pages = "13732--13743",
journal = "Sensors",
issn = "1424-8220",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy

AU - Hingorani, Dina V.

AU - Gonzalez, Sandra I.

AU - Li, Jessica F.

AU - Pagel, Mark "Marty"

PY - 2013/10/11

Y1 - 2013/10/11

N2 - The development and validation of MRI contrast agents consisting of a lanthanide chelate often requires a determination of the concentration of the agent in ex vivo tissue. We have developed a protocol that uses 70% nitric acid to completely digest tissue samples that contain Gd(III), Dy(III), Tm(III), Eu(III), or Yb(III) ions, or the MRI contrast agent gadodiamide. NMR spectroscopy of coaxial tubes containing a digested sample and a separate control solution of nitric acid was used to rapidly and easily measure the bulk magnetic susceptibility (BMS) shift caused by each lanthanide ion and gadodiamide. Each BMS shift was shown to be linearly correlated with the concentration of each lanthanide ion and gadodiamide in the 70% nitric acid solution and in digested rat kidney and liver tissues. These concentration measurements had outstanding precision, and also had good accuracy for concentrations ≥10 mM for Tm(III) Eu(III), and Yb(III), and ≥3 mM for Gd(III), gadodiamide, and Dy(III). Improved sample handling methods are needed to improve measurement accuracy for samples with lower concentrations.

AB - The development and validation of MRI contrast agents consisting of a lanthanide chelate often requires a determination of the concentration of the agent in ex vivo tissue. We have developed a protocol that uses 70% nitric acid to completely digest tissue samples that contain Gd(III), Dy(III), Tm(III), Eu(III), or Yb(III) ions, or the MRI contrast agent gadodiamide. NMR spectroscopy of coaxial tubes containing a digested sample and a separate control solution of nitric acid was used to rapidly and easily measure the bulk magnetic susceptibility (BMS) shift caused by each lanthanide ion and gadodiamide. Each BMS shift was shown to be linearly correlated with the concentration of each lanthanide ion and gadodiamide in the 70% nitric acid solution and in digested rat kidney and liver tissues. These concentration measurements had outstanding precision, and also had good accuracy for concentrations ≥10 mM for Tm(III) Eu(III), and Yb(III), and ≥3 mM for Gd(III), gadodiamide, and Dy(III). Improved sample handling methods are needed to improve measurement accuracy for samples with lower concentrations.

KW - Bulk magnetic susceptibility

KW - Concentration measurements

KW - Lanthanide metals

KW - Magnetic resonance spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=84885917195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885917195&partnerID=8YFLogxK

U2 - 10.3390/s131013732

DO - 10.3390/s131013732

M3 - Article

C2 - 24152931

AN - SCOPUS:84885917195

VL - 13

SP - 13732

EP - 13743

JO - Sensors

JF - Sensors

SN - 1424-8220

IS - 10

ER -